- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03449420
Predictability of Thromboelastography Parameters in Severe Post Partum Hemorrhage
February 27, 2018 updated by: Pr Isabelle CONSTANT, Hôpital Armand Trousseau
Predictability of Thromboelastography Parameters in Severe Post Partum Hemorrhage : a Retrospective Study
The aim of the study is to determine if thromboelastography parameters can be predictive of severe post partum hemorrhage.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
100
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Women presenting with a post partum hemorrhage
Description
Inclusion Criteria:
- Women presenting with a post partum hemorrhage
- needing sulprostone infusion
- during third trimester of pregnancy
Exclusion Criteria:
- known coagulation disorders
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Post Partum Hemorrhage
Patients presenting with a post partum hemorrhage.
A thromboelastography analysis is realized at discretion of the anesthesiologist in charge
|
TEG5000® : Kaolin and Functional Fibrinogen tests on native blood sample
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Calculated blood loss
Time Frame: during the 24 hours after delivery
|
Calculated blood loss at 24 hours after delivery (Sum of the volume of blood transfused and the volume of blood loss calculated by the decrease in hematocrit.)
|
during the 24 hours after delivery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Agnes Rigouzzo, MD, Hopital Armand Trousseau
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2012
Primary Completion (Actual)
July 1, 2015
Study Completion (Actual)
July 1, 2015
Study Registration Dates
First Submitted
March 30, 2017
First Submitted That Met QC Criteria
February 27, 2018
First Posted (Actual)
February 28, 2018
Study Record Updates
Last Update Posted (Actual)
February 28, 2018
Last Update Submitted That Met QC Criteria
February 27, 2018
Last Verified
February 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ArmandTrousseau
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post Partum Hemorrhage
-
Yariv yogevRabin Medical CenterUnknownPost-Partum Hemorrhage
-
Laboratoire français de Fractionnement et de BiotechnologiesCompleted
-
Hackensack Meridian HealthCompletedPost-partum Hemorrhage (PPH)United States
-
Tampere University HospitalCompletedBlood Transfusion | Post-partum HemorrhageFinland
-
University Hospital, MontpellierNot yet recruitingPost Partum Haemorrhage
-
Oxytone Bioscience BVTerminatedPost Partum HaemorrhageSweden
-
North Bristol NHS TrustFerring Pharmaceuticals; University of Bristol; University Hospitals Bristol... and other collaboratorsCompleted
-
Qazvin University Of Medical SciencesCompletedPost Partum HaemorrhageIran, Islamic Republic of
-
Hospices Civils de LyonUnknownPost Partum HaemorrhageFrance
-
University of PretoriaCompletedPrevention of Post Partum HaemorrhageSouth Africa
Clinical Trials on thromboelastography
-
University Hospitals, LeicesterCompletedPost-Dural Puncture Headache | Low Pressure HeadacheUnited Kingdom
-
The University of Texas Health Science Center,...CompletedIschemic Stroke | Brain HemorrhageUnited States
-
Francesco EgroNot yet recruiting
-
Cardiochirurgia E.H.TerminatedBleeding | Blood TransfusionItaly
-
Vanderbilt University Medical CenterWithdrawnCirrhosis, Liver | Coagulopathy | GastroIntestinal Bleeding
-
Rajiv Gandhi Cancer Institute & Research Center...Completed
-
Tel-Aviv Sourasky Medical CenterUnknownLiver Cirrhosis | Coagulopathy
-
University of PennsylvaniaPrinceton UniversityCompletedTrauma | Trauma Injury | CoagulopathyUnited States
-
Washington University School of MedicineOrthopedic Research and Education FoundationTerminatedNeuromuscular ScoliosisUnited States
-
Western Galilee Hospital-NahariyaCompletedBariatric Patients Undergoing Bariatric SurgeryIsrael